NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹33 Cr | ₹21 Cr | ₹15 Cr | ₹21 Cr | ₹14 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹14 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 54.46 | |
| Mar2024 | ₹21 Cr | 40.13 | |
| Mar2023 | ₹15 Cr | -28.97 | |
| Mar2022 | ₹21 Cr | 51.58 | |
| Mar2021 | ₹14 Cr | - | |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹2,008.5 Cr | 2.4% | 5.4% | 126.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 2.4% |
5.4% |
126.8% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses